Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02871596 · ClinicalTrials.gov registry record · NA

Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds

A NA study of Healthy, sponsored by Pharmanex.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT02871596: Completed NA study of Healthy, sponsored by Pharmanex.

NCT02871596 is a NA study of Healthy that has completed, run by Pharmanex. The registered enrollment target is 27 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02871596, a NA study of Healthy, has completed, sponsored by Pharmanex.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine the effects of both an anthocyanin-rich polyphenol blend and an anthocyanin-rich polyphenol blend combined with a prebiotic blend on fecal microbiota metabolism (assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis) and fecal microbiota composition (assessed by next generation sequencing).

Conditions Studied

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Flavonoids
  • DIETARY_SUPPLEMENT Flavonoids+Prebiotics

Study Locations (1)

Utah

  • Utah State University - Logan

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2016-08
Est. Completion 2017-02
Phase NA

Sponsor

Pharmanex

13 total trials

What the Registry Record Tells You About NCT02871596

The ClinicalTrials.gov registry entry for NCT02871596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Pharmanex, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT02871596 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT02871596 about?

NCT02871596 is a clinical study titled "Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds". The purpose of the study is to determine the effects of both an anthocyanin-rich polyphenol blend and an anthocyanin-rich polyphenol blend combined with a prebiotic blend on fecal microbiota metabolism (assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis) and fecal microbiot...

What is the current status of trial NCT02871596?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-08. Estimated completion is 2017-02.

What conditions does trial NCT02871596 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02871596?

The interventions under investigation include: Placebo (OTHER), Flavonoids (DIETARY_SUPPLEMENT), Flavonoids+Prebiotics (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02871596?

This trial is sponsored by Pharmanex, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02871596 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.